Opexa Therapeutics, Inc. (NASDAQ:OPXA), a company developing Tcelna ™, a novel T-cell therapy for multiple sclerosis (MS), today announced that Neil Warma, President and Chief Executive Officer, will participate in two upcoming industry conferences. Details regarding these events are as follows:
Intellectual Property Owners Association (IPO) Annual Meeting
This conference will take place September 9-11, 2012 at the JW Marriott Hill Country in San Antonio, Texas.
|--||Keynote Luncheon Address|
|Delivered by Mr. Warma|
|Tuesday, September 11, 2012, 12:00 – 1:30 p.m. CT|
Each year, the organizers of the IPO Annual Meeting invite one CEO to deliver a keynote luncheon address. This year, Mr. Warma has been selected to provide insight on the role of intellectual property rights from the perspective of business.The 8 th Annual Burrill Personalized Medicine Meeting This meeting of researchers, drug developers, analysts, investors and other life science industry representatives will take place September 13-14, 2012 at the Bentley Reserve & Conference Center in San Francisco.
|--||“Personalized Medicine From a Drug Developer’s Point of View”|
|Panel participation by Mr. Warma|
|Friday, September 14, 2012, 9:30 – 10:30 a.m. PT|